// App-Quantinova.ai

: RBC-Specific CD47 Pruning Confers Protection and Underlies the Transient Anemia in Patients Treated with Anti-CD47 Antibody 5F9

Researchers

Presenter

  • James Y Chen

Principal Investigators

  • Kelly Marie McKenna

  • Timothy S Choi

  • Jiaqi Duan

  • Lynette Brown

  • Jennifer J Stewart

  • Kavitha Sompalli

  • Paresh Vyas

  • Stanley Schrier

  • Ravindra Majeti

  • Irving L Weissman

  • Kyle Elrod

  • Mark Ping Chao

  • Chris H Takimoto

  • Jie Liu

  • Jens-Peter Volkmer

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • Forty Seven, Inc, Menlo Park, CA

  • Flow Contract Site Laboratory, Bothell, WA

  • IGF Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Department of Medicine, Division of Oncology, Stanford University, Stanford, CA

  • Cancer Center and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute myelocytic leukemia

  • Anemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved